• Members
  • Clients
  • Providers
  • Pharmacies
Abarca-logo

  • what we do
  • who we serve
  • who we are
  • how we think
  • careers
  • contact us
  • home
  • what we do
  • who we serve
  • who we are
  • how we think
  • contact us
  • Members
  • Clients
  • Providers
  • Pharmacies
  • Careers

News

Latest Stories

AssuraBetter CareCase StudiesClinicalDarwinNewsPharmacyTrends
Abarca's financial model Assura receives PBMI Excellence Award for Cost Containment Strategies

9-15-2022

Abarca’s financial model Assura receives PBMI Excellence Award for Cost Containment Strategies

Abarca Health: Long-Acting Insulin Biosimilars & Unbranded Biologics for the treatment of diabetes types 1 and 2

9-9-2022

Long-Acting Insulin Biosimilars & Unbranded Biologics for the treatment of diabetes types 1 and 2

Abarca Health: What you need to know: New CMS Basal Insulin measure

8-23-2022

What you need to know: New CMS Basal Insulin measure

Abarca Health: What You Should Know About Monkeypox

8-14-2022

What You Should Know About Monkeypox

Abarca Health: Jason Borschow interviewed on the PCMA podcast

7-14-2022

Listen to Jason Borschow’s interview on the PCMA podcast

Abarca presented on the results of it's home delivery pharmacy program, Triple-S en Casa, at AMCP 2022

5-4-2022

Abarca presented on the results of it’s home delivery pharmacy program, Triple-S en Casa, at AMCP 2022

Abarca holds summit to discuss the future of healthcare: Corporate culture identified as a critical tool to tackle the Great Resignation’s effects

4-28-2022

Abarca holds summit to discuss the future of healthcare: Corporate culture identified as a critical tool to tackle the Great Resignation’s effects

Independent Methodology Review Affirms Abarca Solution is Transparent & Predictable

4-20-2022

Independent methodology review affirms Abarca’s net cost pricing solution—Assura—is transparent & predictable

Jason Borschow, Abarca Founder & CEO, discusses Assura on the HealthBiz Podcast

3-30-2022

Jason Borschow discusses Assura on the HealthBiz Podcast

2-24-2022

Beneficial impacts of SGLT-2 Inhibitors on Cardiovascular Disease

OUR JOURNEY

JOIN THE REVOLUTION

Why can’t healthcare be awesome? We say it can. And we are making it awesome for millions of consumers across America and the plan sponsors that serve them. Learn more.

Contact Us
  • What We Do
  • Who We Serve
  • Who We Are
  • How We Think
  • Contact
  • Careers
  • Members
  • Clients
  • Providers
  • Pharmacies
  • Privacy Policy
  • Terms & Conditions
©2025 Abarca Health LLC. All Rights Reserved
back to top Back to top

You are leaving Abarca's website and going to a third-party website. That website may have a different privacy policy and security than Abarca. Abarca and its affiliates are not responsible for the products, services, and content on the third-party website. Do you want to go to the third-party website?

YES